ArticleEuropean urology2021

Nascent Prostate Cancer Heterogeneity Drives Evolution and Resistance to Intense Hormonal Therapy.

Scott Wilkinson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.